查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1867162

胃腸道器械市場按產品類型、應用、最終用戶和技術分類－2025-2032年全球預測

Gastrointestinal Devices Market by Product Type, Application, End User, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃腸道設備市場規模將達到 149.1 億美元，複合年成長率為 7.90%。

關鍵市場統計數據
基準年 2024 81.1億美元
預計年份：2025年 87.6億美元
預測年份 2032 149.1億美元
複合年成長率 (%) 7.90%

本文簡要介紹了臨床促進因素、技術加速發展和相關人員的優先事項將如何塑造胃腸道器材創新的未來。

胃腸道醫療器材領域正處於臨床需求、技術快速發展和醫療服務模式不斷演變的交會點。近年來，診斷影像、治療性內視鏡和止血技術取得了全面進步，這些進步的結合使得臨床決策能夠更早做出，並減少了侵入性干預。這些趨勢的促進因素包括：對微創手術的需求日益成長、對門診和日間護理的重視，以及對高解析度視覺化以識別細微黏膜病變的需求。為此，醫療設備開發商和臨床團隊正在嘗試開發整合卓越光學性能、精密輔助器具和軟體驅動工作流程的平台，以縮短手術時間並提高治療精度。

深入分析臨床實務、技術和商業模式的變革性轉變如何重塑手術地點、設備採用和競爭動態。

胃腸道器械領域正處於變革的關鍵時期，臨床路徑和商業模式正在轉變。高解析度成像和小型化平台使得病變早期檢測成為可能，並影響診斷演算法和治療策略。同時，光學技術、機器人技術和軟體分析的融合正在催生新型混合平台，這些平台兼具診斷準確性和精準介入能力，並將手術從住院轉移到門診和日間手術中心。

對2025年美國關稅對胃腸道器械製造商供應鏈、籌資策略和商業計劃的影響進行全面檢驗

2025年美國關稅政策對全球胃腸器械製造商的供應鏈造成了不利影響，從多方面衝擊了零件採購、生產策略和定價策略。擁有垂直整合供應鏈和國內生產能力的製造商受到的影響相對較小，而那些嚴重依賴進口零件和成品的製造商則不然。因此，採購部門必須重新評估供應商多元化和近岸外包的機會，以降低相關關稅帶來的風險。

全面的細分洞察，闡釋產品類型、臨床應用、最終用戶和技術選擇如何驅動差異化應用和市場定位。

細分市場分析表明，在整個胃腸病學領域，產品多樣性和功能專業化是商業化策略和臨床應用路徑的核心。依產品類型分析，主要器械類別包括膠囊內視鏡系統、內視鏡成像系統、內視鏡治療器械和止血器械。在內視鏡成像領域，高清內視鏡、超細內視鏡和影像內視鏡等細分子類別分別針對不同的臨床應用場景：提高黏膜可視性、進入解剖結構狹窄的腔體以及整合數位化工作流程。內視鏡治療器械也呈現類似的分類，擴張球囊用於結構性介入治療，息肉切除器械用於切除病變，支架用於維持管腔通暢。這些器械的選擇取決於病變特徵和手術目標。止血裝置進一步細分為止血夾、止血粉和熱凝固裝置，選擇依據出血病因、可近性和臨床醫師的偏好。

策略性區域洞察：詳細闡述美洲、歐洲、中東和非洲以及亞太地區之間的差異將如何影響醫療器材的採用、證據要求和商業性策略。

區域趨勢將對胃腸道器材的臨床功能優先順序、報銷關鍵因素和上市策略產生重大影響。在美洲，醫療服務模式的轉變正推動著向門診治療的轉型、醫療系統的整合，以及對既能提高診療效率又能保持強力臨床證據支持的器械的需求。該地區普遍採用與流程效率和集中採購機制相契合的技術，但對可靠的上市後數據和可互操作系統的需求也同樣迫切。

關鍵的企業策略和競爭行動揭示了平台領導者、敏捷創新者和製造合作夥伴如何塑造市場走向。

胃腸道器械領域由成熟的平台供應商、專業創新者和垂直整合的製造商組成。主要企業通常會投資於全面的臨床試驗、嚴格的上市後監測以及與醫療系統的合作，以證明其產品的價值。這些企業利用模組化平台實現逐步升級，從而推動長期用戶群的獲利，並透過耗材和配件獲得持續收入。

為製造商和供應商提供切實可行的、優先排序的建議，以加速臨床應用、增強韌性並實現商業性差異化。

產業領導者應優先採取一系列切實可行的措施，以在胃腸道器械領域實現臨床、營運和商業性價值。首先，將產品開發與可衡量的臨床結果和營運效率提升相結合，使採購委員會能夠輕鬆量化其價值。投資於產生真實世界證據，以證明其能夠縮短手術時間、降低併發症發生率並提高診斷準確性，從而加快支付方和醫療服務提供者的接受度。其次，實現供應鏈多元化並開發模組化設計，以便在不影響臨床療效的前提下進行組件替換，從而降低政策主導的成本衝擊風險，並支持靈活生產。

對三角測量調查方法的清晰解釋，該方法結合了初步臨床發現、二次文獻檢驗和基於情境的供應鏈分析。

本執行摘要摘要的研究綜合採用了一種三角測量法，結合了主要相關利益者的對話、二手證據綜合以及基於情境的供應鏈分析。一手資料包括對臨床意見領袖、採購人員和產品開發負責人進行的結構化訪談，以收集關於可用性、臨床優先事項和商業性限制的實際觀點。第二手資料則利用了同行評審的臨床文獻、監管指導文件和已發布的程序最佳實踐，以檢驗臨床性能聲明並確保其符合當前的護理標準。

簡潔扼要的結論摘要了技術創新、供應鏈韌性和證據生成如何決定永續應用和價值創造。

總之，胃腸器材產業的特點是技術快速進步、醫療服務模式不斷轉變，以及日益複雜的商業環境，該環境重視實證創新和營運韌性。高清影像、機器人技術和新型止血方法正在重新定義診斷和治療的可能性，而不斷擴大的門診服務和區域差異則要求制定量身定做的商業策略。 2025 年關稅凸顯了供應鏈彈性和成本模型（考慮總到岸成本而非僅考慮組件成本）的策略重要性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 開發配備人工智慧的膠囊內視鏡系統用於消化系統疾病的早期檢測
  • 擴大微創機器人輔助腔內手術在胃腸道治療的應用
  • 將即時遠端監測感測器整合到智慧胃腸道支架和導管中
  • 擴大可生物分解聚合物基食道和結腸支架的應用，以減少併發症
  • 用於靶向胃腸道治療的自動化精準藥物輸送系統的進展
  • 擴大一次性內視鏡的使用範圍，以提高手術安全性並減少交叉感染

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 消化系統設備市場（依產品類型分類）

  • 膠囊內視鏡系統
  • 內視鏡成像系統
    • 高清內視鏡
    • 超細內視鏡
    • 影像內視鏡
  • 內視鏡治療設備
    • 膨脹氣球
    • 息肉切除裝置
    • 支架
  • 止血裝置
    • 夾子
    • 止血粉
    • 熱凝固設備

第9章 按應用分類的消化系統設備市場

  • 出血控制
    • 機械止血
    • 噴霧型止血劑
    • 熱凝固
  • 診斷影像
    • 病灶可視化
    • 運動功能評估
  • 息肉檢測
  • 狹窄擴張

第10章 依最終用戶分類的消化系統設備市場

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 專科診所

第11章 消化系統設備市場（依技術分類）

  • 膠囊內視鏡
  • 光學內視鏡
    • 軟式內視鏡
    • 硬式內視鏡
  • 機器人內視鏡
  • 超音波超音波
    • 線性超音波內視鏡
    • 徑向超音波超音波

第12章：按地區分類的胃腸道器械市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 消化系統器材市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國胃腸道器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Olympus Corporation
    • FUJIFILM Holdings Corporation
    • HOYA CORPORATION
    • Medtronic plc
    • Boston Scientific Corporation
    • KARL STORZ SE & Co. KG
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • Erbe Elektromedizin GmbH
    • CONMED Corporation
Product Code: MRR-7949F05839D3

The Gastrointestinal Devices Market is projected to grow by USD 14.91 billion at a CAGR of 7.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.11 billion
Estimated Year [2025] USD 8.76 billion
Forecast Year [2032] USD 14.91 billion
CAGR (%) 7.90%

Concise introduction framing clinical drivers, technological acceleration, and stakeholder priorities shaping the future of gastrointestinal device innovation

The gastrointestinal devices landscape sits at the confluence of clinical necessity, technological acceleration, and evolving care delivery models. Recent years have seen end-to-end advances in diagnostic imaging, therapeutic endoscopy, and hemostasis that together shift clinical decision making earlier and reduce invasive interventions. These trends are driven by rising demand for minimally invasive procedures, a growing emphasis on outpatient and ambulatory care, and the necessity for higher-resolution visualization to identify subtle mucosal lesions. In turn, device developers and clinical teams are experimenting with integrated platforms that couple superior optics, refined accessory tools, and software-enabled workflows to shorten procedure time and enhance therapeutic precision.

Against this backdrop, stakeholders from hospital systems to specialty clinics are prioritizing devices that demonstrably improve throughput, lower complications, and enable remote or hybrid care pathways. Policymakers and payers are also influencing adoption through updated reimbursement frameworks that favor value-based outcomes. Moreover, device manufacturers face an increasingly complex regulatory environment in which evidence generation and post-market surveillance carry heightened importance. Taken together, these dynamics set the stage for a highly competitive innovation cycle, where clinical efficacy, workflow compatibility, and economic value determine which technologies achieve scale and which remain niche solutions.

In-depth analysis of the transformative clinical, technological, and commercial shifts reshaping procedure locations, device adoption, and competitive dynamics

The gastrointestinal device landscape is undergoing transformative shifts that are altering clinical pathways and commercial models. Technologically, higher-definition imaging and miniaturized platforms are enabling lesion detection at earlier stages, thereby influencing diagnostic algorithms and therapeutic intent. Concurrently, the convergence of optics, robotics, and software analytics is producing new hybrid platforms that couple diagnostic clarity with precise intervention capabilities, shifting procedural volumes from inpatient to ambulatory settings.

Operationally, the migration toward outpatient and ambulatory surgical centers is reshaping purchasing priorities; providers prioritize disposables that reduce turnover time and capital equipment that delivers robust utilization metrics. Meanwhile, digital integration, including enhanced image management and procedural analytics, is enabling performance benchmarking and remote proctoring, which accelerate clinician adoption curves. Regulatory and reimbursement practice updates are further incentivizing devices that show clear outcomes and cost-efficiencies. In market terms, smaller fast-moving innovators are challenging incumbent suppliers by targeting unmet clinical niches with focused, evidence-backed solutions. As a result, the competitive landscape favors agility, clinical trial rigor, and scalable manufacturing strategies that can support rapid market entry and iterative device improvements.

Comprehensive examination of how the 2025 U.S. tariffs reshaped supply chains, sourcing strategies, and commercial planning across gastrointestinal device makers

The tariff environment introduced by the United States in 2025 has created headwinds across global supply chains for gastrointestinal device manufacturers, with layered effects on component sourcing, manufacturing strategies, and pricing approaches. Manufacturers with vertically integrated supply chains or domestic production capacity experienced relative insulation compared with those that rely heavily on imported subassemblies or finished devices. As a consequence, procurement teams have had to reassess supplier diversity and nearshoring opportunities to mitigate exposure to applied duties.

In practice, the cumulative tariff impact extended beyond direct cost increases, influencing contractual negotiations and lead-time planning. OEMs and contract manufacturers began to restructure agreements to shift risk or incorporate tariff clauses, while strategic buyers accelerated dual-sourcing strategies to preserve continuity. Furthermore, some firms responded by qualifying alternative suppliers from tariff-favored regions or by investing in modular design changes that allowed substitution of affected components without compromising clinical performance. Importantly, this period strengthened the business case for greater supply chain transparency and scenario planning, with commercial teams increasingly modeling total landed cost rather than unit price alone. Taken together, the tariff developments underscored the necessity for resilience-oriented procurement, flexible manufacturing footprints, and commercial strategies that anticipate policy volatility without undermining clinical adoption timelines.

Holistic segmentation insights explaining how product categories, clinical applications, end users, and technology choices drive differentiated adoption and positioning

Segmentation insight reveals that product diversity and functional specialization are central to commercialization strategies and clinical adoption pathways across the gastrointestinal space. When analyzed by product type, key device categories include capsule endoscopy systems, endoscopic imaging systems, endotherapy devices, and hemostasis devices. Within endoscopic imaging, the differentiated subcategories of high-definition endoscopes, ultrathin endoscopes, and video endoscopes each address distinct clinical use cases: enhanced mucosal visualization, access to anatomically narrow lumens, and integrated digital workflows respectively. Endotherapy devices display similar stratification, where dilation balloons serve structural interventions, polypectomy devices address lesion resection, and stents support luminal patency; the choice among these tools often depends on lesion characteristics and procedural intent. Hemostasis devices further stratify into clips, hemostatic powders, and thermal coagulation devices, each selected based on bleeding etiology, accessibility, and clinician preference.

From an application standpoint, devices are deployed across bleeding management, diagnostic imaging, polyp detection, and stricture dilation. Bleeding management itself breaks down into mechanical hemostasis, sprayable hemostats, and thermal coagulation modalities, with selection influenced by bleed source and procedural context. Diagnostic imaging applications include lesion visualization and motility assessment, reflecting a dual focus on structural and functional diagnostics. In terms of end users, the buyer landscape spans ambulatory surgical centers, diagnostic centers, hospitals, and specialty clinics, each with different purchasing cycles, capital constraints, and utilization expectations. Finally, the technology axis differentiates capsule endoscopy, optical endoscopy, robotic endoscopy, and ultrasound endoscopy. Optical systems further bifurcate into flexible and rigid endoscopes, while ultrasound endoscopy differentiates into linear and radial ultrasound endoscopes, reflecting divergent imaging geometries and clinical indications. Integrating these segmentation perspectives clarifies how product development, commercial positioning, and evidence generation must align to meet the heterogeneous needs of clinicians and care settings.

Strategic regional insights detailing how Americas, Europe, Middle East & Africa, and Asia-Pacific differences shape device adoption, evidence needs, and commercial approaches

Regional dynamics materially influence prioritization of clinical features, reimbursement levers, and go-to-market strategies for gastrointestinal devices. In the Americas, healthcare delivery trends emphasize outpatient shift, consolidation of health systems, and an appetite for devices that improve throughput while maintaining strong clinical evidence. This region commonly demonstrates rapid uptake of technologies that align with procedural efficiency and centralized purchasing mechanisms, but also expects robust post-market data and interoperable systems.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement pathways means market entry strategies must be highly localized. Western European markets often demand rigorous clinical validation and demonstrate steady adoption for high-definition imaging and integrated platforms, whereas some emerging markets in the region prioritize cost-effective disposables and modular solutions. In the Middle East and Africa, infrastructure constraints and import logistics drive preference for durable equipment, simplified maintenance, and flexible training support. Across Asia-Pacific, diverse healthcare delivery models range from highly advanced tertiary care centers that adopt leading-edge endoscopic robotics to rapidly growing ambulatory networks in urban centers seeking commercially viable, scalable devices. Procurement strategies here frequently balance accelerated adoption in metropolitan hubs against price sensitivity in broader geographies. Recognizing these regional distinctions enables manufacturers to tailor clinical evidence packages, service models, and commercial approaches in ways that respect local decision drivers and accelerate sustainable adoption.

Key corporate strategies and competitive behaviors revealing how platform leaders, agile innovators, and manufacturing partners shape market trajectories

Competitive dynamics in the gastrointestinal devices arena are defined by a mix of established platform providers, targeted innovators, and vertically integrated manufacturers. Leading firms typically invest in comprehensive clinical programs, rigorous post-market surveillance, and partnerships with healthcare systems to demonstrate value. These companies often leverage modular platforms that allow incremental upgrades, facilitating long-term installed-base monetization and recurring revenue from consumables and accessories.

At the same time, smaller specialist firms and start-ups drive innovation in narrow clinical niches by rapidly iterating on design and leveraging focused clinical trials to capture early adopters. Their agility enables experimentation with alternative business models, such as service-based offerings or bundled procedural pricing, which can accelerate penetration in ambulatory and diagnostic center settings. Contract manufacturing organizations and component specialists have also become strategic partners; they enable cost-effective scaling and help OEMs navigate tariff-induced supply chain shifts by offering distributed manufacturing footprints. Across this ecosystem, companies that align rigorous clinical evidence with clear economic arguments and strong training and service models tend to outperform peers. Strategic alliances, co-development arrangements, and targeted acquisitions remain common approaches to augment technology portfolios and accelerate access to complementary channels and geographies.

Practical and prioritized recommendations for manufacturers and providers to enhance adoption, resilience, and commercial differentiation across clinical settings

Industry leaders should prioritize a set of pragmatic actions to capture clinical, operational, and commercial value across the gastrointestinal device landscape. First, align product development with measurable clinical outcomes and workflow efficiency gains so that procurement committees can readily quantify value. Investing in real-world evidence generation that demonstrates reduced procedure time, lower complication rates, or improved diagnostic yields will accelerate payer and institutional acceptance. Second, diversify supply chains and develop modular designs that allow component substitution without clinical compromise; this will reduce exposure to policy-driven cost shocks and support flexible manufacturing.

Third, tailor go-to-market approaches by end-user segment and region, recognizing that hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics have different capital cycles and utilization expectations. Fourth, build robust training and service programs that reduce learning curves and ensure consistent clinical outcomes; remote proctoring and digital training modules can be cost-effective ways to scale education globally. Fifth, explore innovative commercial models such as outcome-linked pricing, refurbished equipment programs, and consumable subscription models to align incentives with volume and value. Finally, pursue targeted partnerships to complement internal capabilities-whether for imaging software, robotics, or advanced materials-so that product roadmaps can accelerate while mitigating integration risk. Collectively, these actions can improve adoption velocity and create defensible value propositions in a competitive marketplace.

Transparent description of the triangulated research methodology combining primary clinical insights, secondary literature validation, and scenario-based supply chain analysis

The research synthesis underpinning this executive summary employed a triangulated methodology that combined primary stakeholder engagements with secondary evidence synthesis and scenario-based supply chain analysis. Primary inputs included structured interviews with clinical opinion leaders, procurement executives, and product development leaders to capture frontline perspectives on usability, clinical priorities, and commercial constraints. Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents, and published procedural best practices to validate clinical performance claims and to ensure alignment with current standards of care.

To understand operational resilience, scenario modeling was conducted to evaluate supply chain disruption vectors and tariff impacts, assessing mitigation options such as supplier diversification and nearshoring. Data validation steps included cross-referencing clinician-reported preferences with device utilization trends and post-market safety bulletins. The methodological approach prioritized transparency in assumptions, documented data provenance, and iterative validation with domain experts to minimize bias. Where evidence gaps were identified, recommended data collection pathways are included to support future iterations of the analysis, such as focused clinical registries or payer claims modeling to better quantify downstream economic outcomes.

Concise conclusion summarizing how technological innovation, supply chain resilience, and evidence generation determine sustainable adoption and value creation

In conclusion, the gastrointestinal devices domain is characterized by rapid technological progress, shifting care delivery paradigms, and an increasingly complex commercial environment that rewards evidence-driven innovation and operational resilience. High-definition imaging, robotics, and novel hemostasis modalities are redefining diagnostic and therapeutic possibilities, while outpatient care growth and regional variations necessitate tailored commercial strategies. The 2025 tariffs highlighted the strategic importance of supply chain flexibility and cost modeling that account for total landed cost rather than component price alone.

Looking ahead, organizations that pair rigorous clinical validation with adaptable manufacturing and pragmatic go-to-market models will be best positioned to scale. Equally important is the ability to provide comprehensive training and service to ensure consistent outcomes across diverse clinical settings. Ultimately, success will hinge on aligning product performance with measurable clinical benefit and economic value, enabling stakeholders to adopt innovations that improve patient care while sustaining long-term commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of AI-powered capsule endoscopy systems for early gastrointestinal disease detection
  • 5.2. Expansion of minimally invasive robotic-assisted endoluminal procedures in GI treatments
  • 5.3. Integration of real-time remote monitoring sensors in smart gastrointestinal stents and catheters
  • 5.4. Emerging adoption of biodegradable polymer-based esophageal and colonic stents to reduce complications
  • 5.5. Advances in automated precision drug delivery systems for targeted gastrointestinal therapy
  • 5.6. Growth of disposable single-use endoscopes to enhance procedure safety and reduce cross-contamination

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Devices Market, by Product Type

  • 8.1. Capsule Endoscopy Systems
  • 8.2. Endoscopic Imaging Systems
    • 8.2.1. High Definition Endoscopes
    • 8.2.2. Ultrathin Endoscopes
    • 8.2.3. Video Endoscopes
  • 8.3. Endotherapy Devices
    • 8.3.1. Dilation Balloons
    • 8.3.2. Polypectomy Devices
    • 8.3.3. Stents
  • 8.4. Hemostasis Devices
    • 8.4.1. Clips
    • 8.4.2. Hemostatic Powders
    • 8.4.3. Thermal Coagulation Devices

9. Gastrointestinal Devices Market, by Application

  • 9.1. Bleeding Management
    • 9.1.1. Mechanical Hemostasis
    • 9.1.2. Sprayable Hemostats
    • 9.1.3. Thermal Coagulation
  • 9.2. Diagnostic Imaging
    • 9.2.1. Lesion Visualization
    • 9.2.2. Motility Assessment
  • 9.3. Polyp Detection
  • 9.4. Stricture Dilation

10. Gastrointestinal Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Gastrointestinal Devices Market, by Technology

  • 11.1. Capsule Endoscopy
  • 11.2. Optical Endoscopy
    • 11.2.1. Flexible Endoscopes
    • 11.2.2. Rigid Endoscopes
  • 11.3. Robotic Endoscopy
  • 11.4. Ultrasound Endoscopy
    • 11.4.1. Linear Ultrasound Endoscopes
    • 11.4.2. Radial Ultrasound Endoscopes

12. Gastrointestinal Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastrointestinal Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastrointestinal Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Olympus Corporation
    • 15.3.2. FUJIFILM Holdings Corporation
    • 15.3.3. HOYA CORPORATION
    • 15.3.4. Medtronic plc
    • 15.3.5. Boston Scientific Corporation
    • 15.3.6. KARL STORZ SE & Co. KG
    • 15.3.7. Becton, Dickinson and Company
    • 15.3.8. Cook Medical LLC
    • 15.3.9. Erbe Elektromedizin GmbH
    • 15.3.10. CONMED Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GASTROINTESTINAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GASTROINTESTINAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC